(PharmaNewsWire.Com, December 01, 2017 ) Latin America RNA Analysis Market size was around USD 230 million in 2016. It is expected to grow at a CAGR of 12% to reach USD 440 million by 2021. It captures 12% of the global market. The market is mainly driven by the increasing technological advancements, increasing investment in research and development by biotechnology and pharmaceutical companies, rising government and private funding, and growing preference for personalized medicines.
However, lack of skilled professionals in the transcriptomics field and lack of efficient bioinformatics and data analysis tools to analyse enormous data generated from the high-throughput sequencing technologies expected to restrain the growth of this market to a certain extent.
Latin America RNA Analysis Market segmentation by end user, type, and application. By end user the market is segmented into Academic Research & Government Institutes, Pharmaceutical & Biotechnology Companies, and Hospitals & Diagnostic Centres. By type the market is segmented into Microarrays, Polymerase Chain Reaction (PCR), Sequencing Technologies, and RNAI Gene Silencing. Microarrays are further sub-segmented into Reagents, Instruments and Software. Polymerase Chain Reaction (PCR) is further sub-segmented into Reagents, Instruments and Software. Sequencing Technologies are further sub-segmented into Sanger Sequencing (Reagents, Instruments and Software), and Next Generation Sequencing (NGS) (Reagents, Instruments and Software). RNAI Gene Silencing is further sub-segmented into Reagents, Instruments and Software. By application the market is segmented into Clinical Diagnosis, Drug Discovery, and Toxic genomics.
Latin America RNA Analysis Market geographical segmentation by Mexico, Brazil, Chile, Argentina and others. But still, in the forecast period, emerging economies like Latin America are anticipated to form new revenue-generating pockets for the market players. Economic developments and increasing government funding to support new product developments are the major factors fuelling the growth of market in these regions.
The major RNA Analysis Market leaders are Illumina Inc. (U.S.), Qiagen N.V. (Germany), Affymetrix Inc. (U.S.), Agilent Technologies Inc. (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Sigma Aldrich (U.S.), Fluidigm Corporation (U.S.), Bio-Rad Laboratories Inc. (U.S.), GE Healthcare (U.S.), and Thermofisher Scientific Inc. (U.S.).
Market Segmentation: 1) End User 2) Type 3) Application
About us: Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, they cater to the needs of both individual and corporate clients. From all-encompassing umbrella markets to extremely specific niche markets covering all the major regions across the globe as part of the research scope, their research services offer one of a kind specialties with competitive pricing options.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
